Active, not recruitingPhase 2NCT05676034
AMX0035 in Adult Patients With Wolfram Syndrome
Studying Wolfram syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Amylyx Pharmaceuticals Inc.
- Principal Investigator
- Camille Bedrosian, MD, MDAmylyx Pharmaceuticals
- Intervention
- AMX0035(drug)
- Enrollment
- 12 enrolled
- Eligibility
- 17 years · All sexes
- Timeline
- 2023 – 2026
Study locations (1)
- Washington University, St Louis, Missouri, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05676034 on ClinicalTrials.govOther trials for Wolfram syndrome
Additional recruiting or active studies for the same condition.